Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) (C-Term) Peptide

Details for Product No. ABIN1381977, Supplier: Log in to see
Protein Name
  • FTDCR1B
  • HS
  • HSNIK
  • NIK
  • FLH21957
  • HGK
  • MEKKK4
  • F23F1.4
  • F23F1_4
  • mitogen-activated protein kinase kinase kinase 14
  • Nik
  • aly
  • mitogen-activated protein kinase kinase kinase 14
  • mitogen-activated protein kinase kinase kinase kinase 4
  • MAP3K14
  • MAP4K4
  • Map3k14
  • MAPKKK14
Protein Region
C-Term
Origin
Human
2
2
1
Application
Blocking Peptide (BP)
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Blocked Antibody anti-MAP3K14 antibody (Mitogen-Activated Protein Kinase Kinase Kinase 14) (C-Term) (ABIN1030544)
Characteristics 17 amino acids near the carboxy terminus of human NIK.
Human
Research Area Transcription Factors
Application Notes NIK peptide is used for blocking the activity of NIK.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Malinin, Boldin, Kovalenko, Wallach: "MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1." in: Nature, Vol. 385, Issue 6616, pp. 540-4, 1997 (PubMed).

He, Chen, Farzan, Choe, Ohagen, Gartner, Busciglio, Yang, Hofmann, Newman, Mackay, Sodroski, Gabuzda: "CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia." in: Nature, Vol. 385, Issue 6617, pp. 645-9, 1997 (PubMed).

Choe, Farzan, Sun, Sullivan, Rollins, Ponath, Wu, Mackay, LaRosa, Newman, Gerard, Gerard, Sodroski: "The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates." in: Cell, Vol. 85, Issue 7, pp. 1135-48, 1996 (PubMed).